We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
MSLN is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
540.1
Number of samples
349
Samples
Sample
Description
TPM
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
3684.9
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
2738.0
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
2586.4
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
2453.5
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
1981.8
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
1963.3
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
1767.1
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
1765.8
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
1735.6
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
1582.1
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
1494.2
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
1441.9
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
1399.0
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
1389.0
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
1366.2
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
1364.9
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
1350.6
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
1293.8
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
1246.5
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
1234.3
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
1231.8
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
1229.9
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
1180.0
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
1158.9
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
1143.6
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
1103.8
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
1098.5
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
1086.6
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
1062.1
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
1049.1
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
1041.0
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
1034.2
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
1023.9
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
1007.9
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
1005.6
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
986.0
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
986.0
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
979.6
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
968.7
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
967.1
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
957.4
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
956.4
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
951.4
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
949.0
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
932.9
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
926.6
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
922.1
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
920.2
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
916.2
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
911.2
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
910.4
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
907.0
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
894.0
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
888.5
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
882.0
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
844.9
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
840.0
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
838.2
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
832.1
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
830.6
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
827.8
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
827.1
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
825.9
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
825.1
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
822.3
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
819.6
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
817.4
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
812.7
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
801.8
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
801.0
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
797.9
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
796.9
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
787.5
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
779.9
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
774.1
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
772.9
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
764.6
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
753.5
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
745.4
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
742.8
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
736.3
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
733.3
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
729.6
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
719.4
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
716.6
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
701.8
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
701.3
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
700.8
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
694.6
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
693.0
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
677.8
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
675.7
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
673.3
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
667.8
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
666.8
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
666.5
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
666.0
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
661.9
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
660.5
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
656.6
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
651.0
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
643.8
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
643.7
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
639.4
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
634.9
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
634.7
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
634.0
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
633.5
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
628.2
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
625.6
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
624.8
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
618.7
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
618.0
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
615.2
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
615.1
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
613.6
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
612.8
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
610.3
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
608.4
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
604.7
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
602.1
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
598.2
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
590.5
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
589.7
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
588.6
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
588.4
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
583.4
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
581.0
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
577.8
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
577.1
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
576.0
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
574.7
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
572.4
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
571.3
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
570.3
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
565.0
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
562.7
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
560.4
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
560.1
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
559.8
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
557.5
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
555.9
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
551.5
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
549.6
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
548.5
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
545.8
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
543.2
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
539.7
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
538.3
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
537.6
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
534.5
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
527.5
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
522.9
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
522.1
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
521.8
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
518.3
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
518.2
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
517.4
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
517.1
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
509.7
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
502.2
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
499.3
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
499.3
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
498.0
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
494.5
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
494.0
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
492.5
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
491.5
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
484.6
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
484.2
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
483.5
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
479.2
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
475.9
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
472.4
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
469.9
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
464.4
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
460.5
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
455.6
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
448.4
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
440.6
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
433.9
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
433.1
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
430.2
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
428.0
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
423.2
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
422.4
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
421.6
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
408.6
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
405.2
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
404.4
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
401.7
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
401.3
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
400.6
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
399.8
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
399.6
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
399.3
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
396.2
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
393.2
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
392.4
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
390.1
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
387.3
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
384.3
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
381.2
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
380.1
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
373.1
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
370.2
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
369.1
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
367.2
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
366.5
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
364.4
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
362.6
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
352.0
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
348.5
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
344.1
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
343.0
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
340.0
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
335.6
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
334.5
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
333.7
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
331.2
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
329.7
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
327.4
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
327.3
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
326.5
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
326.2
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
322.0
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
318.6
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
317.1
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
313.3
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
311.2
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
307.9
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
305.2
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
302.7
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
302.5
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
298.6
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
295.2
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
293.4
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
292.5
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
291.7
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
291.5
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
290.5
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
290.1
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
286.6
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
285.7
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
284.5
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
282.7
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
280.3
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
279.2
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
275.9
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
274.2
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
267.9
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
266.4
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
263.6
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
263.0
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
262.0
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
257.3
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
256.6
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
252.4
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
252.3
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
250.0
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
247.5
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
245.4
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
243.9
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
239.4
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
238.1
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
236.0
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
232.9
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
231.1
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
226.0
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
223.9
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
222.0
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
221.3
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
221.0
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
220.7
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
216.9
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
216.7
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
216.3
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
214.1
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
213.3
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
209.9
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
208.9
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
200.3
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
192.6
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
192.3
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
188.1
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
186.8
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
186.3
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
183.2
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
182.4
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
180.2
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
172.7
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
166.4
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
164.9
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
162.9
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
161.2
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
161.0
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
157.7
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
153.4
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
152.1
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
151.6
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
148.5
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
146.8
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
146.4
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
143.7
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
143.4
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
140.9
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
140.3
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
139.0
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
139.0
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
137.5
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
131.2
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
129.3
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
129.1
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
128.6
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
125.1
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
123.7
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
123.5
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
120.4
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
115.4
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
114.7
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
114.6
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
109.8
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
109.0
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
106.9
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
105.5
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
97.9
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
97.1
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
96.4
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
87.4
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
83.1
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
78.4
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
74.1
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
71.6
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
67.0
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
57.5
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
41.7
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
38.5
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
36.2
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
29.2
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
21.3
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
17.7
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
12.0
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
11.2
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
8.3
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
7.5
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
6.7
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
6.5
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
6.2
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
MSLN is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
489.1
Number of samples
81
Samples
Sample
Description
TPM
DO46356
0 years, female, NA, stage:III, dead, 911 days
2164.7
DO46331
0 years, female, NA, stage:III, dead, 612 days
1477.6
DO46374
0 years, female, NA, stage:III, dead, 1409 days
1405.7
DO46333
0 years, female, NA, stage:III, dead, 359 days
1304.0
DO46376
0 years, female, NA, stage:III, dead, 1430 days
1249.8
DO46364
0 years, female, NA, stage:III, dead, 806 days
1076.4
DO46329
0 years, female, NA, stage:III, dead, 1699 days
1070.6
DO46611
0 years, female, NA, stage:III, dead, 734 days
1067.3
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
1054.7
DO46366
0 years, female, NA, stage:III, dead, 2054 days
968.6
DO46546
0 years, female, NA, stage:III, dead, 1889 days
961.3
DO46350
0 years, female, NA, stage:III, dead, 886 days
872.1
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
872.1
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
823.3
DO46597
0 years, female, NA, stage:III, dead, 393 days
796.2
DO46518
0 years, female, NA, stage:III, alive, 2960 days
756.5
DO46400
0 years, female, NA, stage:III, dead, 719 days
726.5
DO46352
0 years, female, NA, stage:III, dead, 677 days
660.4
DO46342
0 years, female, NA, stage:III, dead, 1398 days
633.8
DO46402
0 years, female, NA, stage:III, dead, 511 days
628.6
DO46576
0 years, female, NA, stage:III, alive, 133 days
626.2
DO46338
0 years, female, NA, stage:III, dead, 596 days
620.2
DO46560
0 years, female, NA, stage:IV, dead, 286 days
598.2
DO46368
0 years, female, NA, stage:III, dead, 2879 days
581.9
DO46340
0 years, female, NA, stage:III, dead, 616 days
567.9
DO46581
0 years, female, NA, stage:III, dead, 408 days
560.7
DO46334
0 years, female, NA, stage:III, dead, 496 days
558.1
DO46384
0 years, female, NA, stage:III, dead, 614 days
551.8
DO46358
0 years, female, NA, stage:III, dead, 423 days
521.4
DO46533
0 years, female, NA, stage:III, alive, 3667 days
514.9
DO46398
0 years, female, NA, stage:III, alive, 437 days
513.7
DO46344
0 years, female, NA, stage:III, dead, 642 days
473.9
DO46372
0 years, female, NA, stage:III, dead, 1326 days
448.7
DO46378
0 years, female, NA, stage:III, alive, 843 days
438.4
DO46606
0 years, female, NA, stage:III, alive, 804 days
431.1
DO46390
0 years, female, NA, stage:III, dead, 374 days
430.6
DO46468
0 years, female, NA, stage:III, alive, 2776 days
427.1
DO46327
0 years, female, NA, stage:III, dead, 184 days
416.7
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
414.1
DO46463
0 years, female, NA, stage:III, dead, 2451 days
395.9
DO46538
0 years, female, NA, stage:III, dead, 1527 days
385.5
DO46571
0 years, female, NA, stage:III, dead, 243 days
369.4
DO46380
0 years, female, NA, stage:III, dead, 1423 days
351.7
DO46448
0 years, female, NA, stage:III, dead, 654 days
345.8
DO46382
0 years, female, NA, stage:IV, dead, 311 days
339.7
DO46508
0 years, female, NA, stage:III, dead, 2101 days
325.3
DO46336
0 years, female, NA, stage:IV, dead, 664 days
316.7
DO46326
0 years, female, NA, stage:III, dead, 701 days
307.9
DO46396
0 years, female, NA, stage:III, dead, 583 days
305.8
DO46354
0 years, female, NA, stage:III, dead, 843 days
294.4
DO46386
0 years, female, NA, stage:III, dead, 1162 days
293.5
DO46392
0 years, female, NA, stage:III, dead, 628 days
283.7
DO46404
0 years, female, NA, stage:III, dead, 690 days
275.5
DO46328
0 years, female, NA, stage:III, dead, 972 days
274.7
DO46591
0 years, female, NA, stage:III, dead, 195 days
269.2
DO46568
0 years, female, NA, stage:III, dead, 320 days
266.3
DO46325
0 years, female, NA, stage:III, dead, 477 days
262.4
DO46330
0 years, female, NA, stage:III, dead, 684 days
255.4
DO46348
0 years, female, NA, stage:IV, dead, 287 days
253.6
DO46551
0 years, female, NA, stage:III, dead, 1055 days
243.3
DO46453
0 years, female, NA, stage:III, dead, 3294 days
233.5
DO46443
0 years, female, NA, stage:III, dead, 2464 days
225.4
DO46346
0 years, female, NA, stage:III, dead, 1187 days
216.9
DO46561
0 years, female, NA, stage:III, dead, 195 days
177.7
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
175.4
DO46432
0 years, female, NA, stage:III, alive, 2218 days
173.5
DO46370
0 years, female, NA, stage:III, dead, 1727 days
172.8
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
166.7
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
153.6
DO46566
0 years, female, NA, stage:III, dead, 673 days
151.5
DO46412
0 years, female, NA, stage:III, dead, 597 days
140.0
DO46493
0 years, female, NA, stage:IV, alive, 839 days
139.5
DO46588
0 years, female, NA, stage:III, dead, 438 days
136.3
DO46602
0 years, female, NA, stage:III, dead, 205 days
133.3
DO46436
0 years, female, NA, stage:III, alive, 3193 days
127.9
DO46388
0 years, female, NA, stage:III, dead, 413 days
103.1
DO46362
0 years, female, NA, stage:III, dead, 1639 days
97.3
DO46528
0 years, female, NA, stage:III, alive, 6139 days
64.3
DO46332
0 years, female, NA, stage:III, dead, 689 days
52.1
DO46408
0 years, female, NA, stage:III, dead, 489 days
51.9
DO46586
0 years, female, NA, stage:III, dead, 1019 days
45.6
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
2.2
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
2.2
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
1.7
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
1.1
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
1.1
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
1.0
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
1.0
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
0.9
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
0.9
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
0.8
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
0.8
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
0.7
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
0.7
285fed94-1495-448e-879b-b55de9_D2
Tumor
0.6
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
0.6
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
0.6
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
0.6
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
0.6
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
0.6
340a3769-3031-41ae-bb08-a2f696_D2
Normal
0.5
161317f3-1a39-438e-af45-cd2502_D2
Tumor
0.5
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
0.5
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
0.5
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
0.5
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
0.5
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
0.5
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
0.4
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
0.4
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
0.4
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.4
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
0.3
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
0.3
a3a26070-fb84-406a-8280-d555e6_D2
Normal
0.3
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
0.3
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
0.3
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
0.3
1a10c200-3895-4648-b951-94f99f_D2
Tumor
0.3
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
0.3
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.3
2f901c90-617e-46da-9fac-d68369_D2
Tumor
0.3
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
0.2
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.2
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
0.2
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
0.1
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
0.1
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
0.1
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
0.1
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
0.1
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
0.1
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
0.1
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
0.1
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
0.1
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
0.1
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
0.1
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.1
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
0.0
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
0.0
a65d8e76-640f-4341-a561-afbb57_D2
Normal
0.0
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
0.0
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
0.0
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
0.0
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
0.0
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
0.0
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.0
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
0.0
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
0.0
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-0.1
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.1
1772e913-f62e-446a-8cf3-720348_D2
Tumor
-0.1
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
-0.1
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
-0.1
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.1
15524912-685a-47ce-a824-567848_D2
Tumor
-0.1
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.1
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
-0.1
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-0.1
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-0.1
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
-0.2
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
-0.2
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
-0.2
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
-0.2
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
-0.2
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.3
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.3
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.3
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.3
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-0.3
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-0.3
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-0.4
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
-0.4
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-0.5
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.5
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
-0.5
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-0.5
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.5
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
-0.5
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
-0.5
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
-0.5
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
-0.6
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.6
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
-0.6
e9d416e7-f661-400a-896e-388545_D2
Tumor
-0.7
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-0.7
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-0.7
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.7
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-0.7
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
-0.8
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
-1.0
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.